🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12417+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12417 recruiting trials

Phase 1RecruitingNCT06204835

ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery

👨‍⚕️ Zhenhua Hu, Ph. D, Institute of Automation, Chinese Academy of Sciences📍 2 sites📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT06960161

Exploring the Use of Phototherapy to Improve CPAP Compliance

🏥 University of Alberta📍 1 site📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT06465550

A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major

👨‍⚕️ Sujiang Zhang, M.D., Shanghai Ruijin Hospital, Shanghai Jiaotong University📍 3 sites📅 Started Jan 2024View details ↗
RecruitingNCT06153147

KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)

🏥 The Hospital for Sick Children📍 1 site📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT06508463

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

👨‍⚕️ Kah Whye Peng, PhD, Mayo Clinic in Rochester📍 2 sites📅 Started Jan 2024View details ↗
NARecruitingNCT06192979

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

👨‍⚕️ Jin Lu, Peking University People's Hospital📍 6 sites📅 Started Jan 2024View details ↗
EARLY_Phase 1RecruitingNCT06047496

Time Restricted Eating in Sleep Apnea

👨‍⚕️ Omar Mesarwi, MD, University of California, San Diego📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06191263

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

🏥 Ryvu Therapeutics SA📍 37 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06053658

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

👨‍⚕️ Eric Jonasch, M D, M.D. Anderson Cancer Center📍 5 sites📅 Started Jan 2024View details ↗
RecruitingNCT06151730

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

👨‍⚕️ Joerg Herrmann, MD, Mayo Clinic in Rochester📍 1 site📅 Started Jan 2024View details ↗
EARLY_Phase 1RecruitingNCT06339593

Regional Monitoring of CF Lung Disease

👨‍⚕️ Jason C Woods, PhD, Cincinnati Children's Hospital Medica Center📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05966519

ROSA Knee Intraoperative Planning Flexibility Study

👨‍⚕️ Yasuharu Nakashima, Kyushu University📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06219239

Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT05910801

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

👨‍⚕️ Yucai Wang, Academic and Community Cancer Research United📍 2 sites📅 Started Jan 2024View details ↗
NAEnrolling by InvitationNCT06798116

Treatment of Periodontal Intrabony Defects With Liquid Platelet-Rich Fibrin Mixed With Denaturated Albumin Gel (ALB_PRF)

👨‍⚕️ Dhaidan Naif Alshammari, Bachelor, faculty of dentistry Mansoura university📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05996536

Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)

👨‍⚕️ Rebecca J Brown, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT07256301

A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

👨‍⚕️ Fengkui Zhang, Dr., The Institute of Hematology & Blood Diseases Hospital (Chinese Academy of Medical Sciences)📍 2 sites📅 Started Jan 2024View details ↗
NARecruitingNCT05410509

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

👨‍⚕️ Andrew Gunn, MD, University of Alabama at Birmingham📍 4 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06179524

CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL

👨‍⚕️ Xiaofan Zhu, Hematology Hospital of the Chinese Academy of Medical Sciences📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06250699

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

👨‍⚕️ meng zhe, Wuhan University📍 1 site📅 Started Jan 2024View details ↗
← PreviousPage 341 of 621Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →